Open AccessExpression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Author(s) -
PLOS ONE Editors
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0215109
Subject(s) - sorafenib , tyrosine kinase , cancer research , acquired resistance , vegf receptors , cancer cell lines , kinase , cancer , medicine , biology , oncology , cancer cell , hepatocellular carcinoma , genetics , receptor